LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.36 | 27.76 | 13 | 320 | 0.0406 | -0.1934 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.06 | 27.76 | 616 | 360 | 1.7111 | 1.3128 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.06 | 27.76 | 17 | 360 | 0.0472 | -0.1242 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.76 | 27.76 | 656 | 401 | 1.6353 | 1.2723 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.76 | 27.76 | 22 | 401 | 0.0548 | -0.0586 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.46 | 27.76 | 644 | 438 | 1.4682 | 1.2025 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.46 | 27.76 | 59 | 438 | 0.1345 | 0.2085 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.17 | 27.76 | 2 | 489 | 0.0041 | -0.4703 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.17 | 27.76 | 681 | 489 | 1.3924 | 1.1665 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.17 | 27.76 | 86 | 489 | 0.1758 | 0.3142 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 13.87 | 27.76 | 5 | 604 | 0.0083 | -0.3200 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 13.87 | 27.76 | 717 | 604 | 1.1857 | 1.0781 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 13.87 | 27.76 | 1 | 604 | 0.0017 | -0.5265 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 13.87 | 27.76 | 136 | 604 | 0.2249 | 0.4297 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 15.58 | 27.76 | 5 | 685 | 0.0073 | -0.3096 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 15.58 | 27.76 | 731 | 685 | 1.0663 | 1.0279 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 15.58 | 27.76 | 1 | 685 | 0.0015 | -0.5125 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 15.58 | 27.76 | 173 | 685 | 0.2523 | 0.4851 | MN20160318_Q01 | H08 |